Stamford, CT, October 2026: TrueNorth Capital Partners LLC is pleased to announce that its wholly-owned subsidiary, TNCP, LLC (“TrueNorth”) acted as exclusive financial advisor to Japan Lifeline Co., Ltd., (TYO 7575) (“JLL”) on its acquisition of 100% of the stock of Cross Vascular, Inc. (“Cross Vascular”), through its wholly-owned subsidiary JLL Med USA Inc. (“JLL Med USA”).

Cross Vascular develops innovative products related to transseptal puncture, an essential procedure for arrhythmia ablation treatment, including RF needles and RF generators and has obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA). Cross Vascular has also established a U.S. intellectual property portfolio that includes four patents issued by the United States Patent and Trademark Office (USPTO). Cross Vascular is based in Solana Beach, California.

The acquisition of Cross Vascular will allow JLL to accelerate the global expansion of its in-house products and establish a business foundation in the United States. JLL leverages Cross Vascular’s technology and accelerates their global expansion in the arrhythmia area, which is expected to experience continued high growth.

Mr. Takeyoshi Egawa, Director and CFO commented, “This acquisition represents an important strategic milestone for JLL. Despite a highly compressed transaction timeline and the complexities inherent in a cross-border process, the transaction was completed successfully and on schedule. We greatly appreciated the dedication, responsiveness, and cross-border M&A execution capabilities of the TrueNorth team, whose support was instrumental throughout the process. We are excited about the opportunities ahead and look forward to realizing the operational and strategic synergies between Cross Vascular and our existing businesses.”

Tsuyoshi (Yoshi) Togo and Yuka Kimoto, Managing Directors acted as Lead Bankers on this transaction with support from Ryusei Hirabayashi, Senior Analyst.

Any further inquiries can be directed to TrueNorth at the contact information provided below:

Yoshi Togo, Managing Director
Direct Dial Phone Number: (203) 817-0284
E-mail address: ttogo@truenorthcp.com

Yuka Kimoto, Managing Director
Direct Dial Phone Number: (203) 817-0283
E-mail address: ykimoto@truenorthcp.com

About Japan Lifeline Co., Ltd.:
Japan Lifeline (TYO 7575), was incorporated in 1981 and is headquartered in Tokyo, Japan, operating as a medical device company that engages in the manufacturing and sale of specialized medical equipment, maintaining a broad portfolio centered around cardiac rhythm management, featuring products such as cardiac pacemakers, implantable cardioverter defibrillators, subcutaneous implantable cardioverter defibrillators, and cardiac resynchronization therapy defibrillators and pacemakers, alongside automated external defibrillators and cardiopulmonary resuscitation support devices, while also making tools for treating heart arrhythmias and blood vessel issues like various catheters for heart mapping and tissue ablation along with stent grafts used to repair damaged blood vessels and aortas, and finally providing equipment for treating digestive and structural heart conditions which covers tools for procedures inside the digestive tract—such as specialized scopes, stents, and balloons—as well as devices to close heart defects and clear blocked blood vessels.

ABOUT Cross Vascular, Inc.:
Cross Vascular was incorporated in 2020 and is based in Solana Beach, California. Cross Vascular develops innovative products related to transseptal puncture, an essential procedure for arrhythmia ablation treatment, including RF needles and RF generators and has obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA). Cross Vascular has also established a U.S. intellectual property portfolio that includes four patents issued by the United States Patent and Trademark Office (USPTO).

About TrueNorth Capital Partners LLC:
TrueNorth provides advisory services to companies seeking advice for middle-market M&A and financing transactions. With offices in Stamford CT, Charleston SC, Central NJ, Tokyo Japan, and London UK, TrueNorth is a boutique investment bank comprised of senior bankers providing a full complement of financial advisory services. Our focus on the middle-market enables us to provide independent, value-added advisory services to privately held middle-market companies, private equity and family office groups and corporate clients, both domestic and international, across a broad range of industries. TrueNorth conducts its securities related business through its wholly owned subsidiary, TNCP, LLC, member FINRA/SIPC.